| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/22/2008 | WO2008060356A2 Methods and compositions for gene therapy |
| 05/22/2008 | WO2008060228A1 Extended release formulations comprising quetipine and methods for their manufacture |
| 05/22/2008 | WO2008060051A1 Transnasal anticonvulsive pharmaceutical composition |
| 05/22/2008 | WO2008059885A1 Gel-like sterilizing/disinfecting composition |
| 05/22/2008 | WO2008059792A1 Method for production of sustained release tablet |
| 05/22/2008 | WO2008059652A1 Disintegrating agent, and tablet and granule each containing the same |
| 05/22/2008 | WO2008059060A1 Liquid pharmaceutical compositions comprising a bisphosphonate compound |
| 05/22/2008 | WO2008059059A1 Pharmaceutical compositions comprising a bisphosphonate compound |
| 05/22/2008 | WO2008059058A1 Hydrogel and biomedical applications thereof |
| 05/22/2008 | WO2008058547A2 Alpha-lactalbumin composition |
| 05/22/2008 | WO2008058461A1 Peg modified exendin or exendin analog and compositions and use thereof |
| 05/22/2008 | WO2008058457A1 A biodegradable crosslinked polyethyleneimine and its uses |
| 05/22/2008 | WO2008058396A1 Papaya mosaic virus-based vaccines for influenza |
| 05/22/2008 | WO2008058381A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058380A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058379A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058366A1 Oil-in-water emulsions, methods of use thereof, methods of preparation thereof and kits thereof |
| 05/22/2008 | WO2008041245A3 Injectable depot composition and it's process of preparation |
| 05/22/2008 | WO2008037502A3 Olanzapine pharmaceutical composition with anhydrous lactose |
| 05/22/2008 | WO2008029282A3 Aqueous formulation comprising an antitumor agent |
| 05/22/2008 | WO2008012365A3 Drug delivery system based on regioselectively amidated hyaluronic acid |
| 05/22/2008 | WO2008000466A3 Use of an antimicrobial hardening alginate material for the topical treatment of wounds and inflammations in human, dental, and veterinary medicine and for cosmetic purposes |
| 05/22/2008 | WO2007133751A3 Base-stabilized polyorthoester formulations |
| 05/22/2008 | WO2007132296B1 Multilayer tablet |
| 05/22/2008 | WO2007128443A3 Spherical or non-spherical microcapsules comprising glp-i peptides, their production and use |
| 05/22/2008 | WO2007122388A3 Nanoparticles containing three various ligands for providing immune responses against infectious agents |
| 05/22/2008 | US20080119572 Treatment for basal cell carcinoma |
| 05/22/2008 | US20080119570 Stable Cosmetic Emulsion With Polyamide Gelling Agent |
| 05/22/2008 | US20080119569 Polymer-based sustained release device |
| 05/22/2008 | US20080119568 Gastrointestinal Absorption Enhancer Mediated By Proton-Coupled Transporter and Its Preparing Method |
| 05/22/2008 | US20080119567 Geranium oil and extracts from roots of Sophora; H. pylori infection; citronellol; sodium/potassium ATPase inhibitors; cardiovascular disorders; gastric ulcers |
| 05/22/2008 | US20080119562 Methods of Inducing Terminal Differentiation |
| 05/22/2008 | US20080119552 Matrix-embedded compositions having organic acids and fatty acids |
| 05/22/2008 | US20080119546 Treatment of hyperproliferative conditions of body surfaces |
| 05/22/2008 | US20080119519 Base Forming Drug-Layered Silicate Hybrid Containing Basic Polymer and its Synthesis Method |
| 05/22/2008 | US20080119504 aporphine 10- and 11-mono-esters and 10,11-asymmetric di-esters; dopaminergic agonist; Parkinson's disease, hemicrania, restless leg syndrome, sexual dysfunction, hyperprolactemia and psychotic disorders |
| 05/22/2008 | US20080119475 comprises a folate receptor ligand capable of binding to activated macrophages or a vitamin/vitamin-receptor binding analog and immunogen, a cytotoxin, or another compound capable of altering macrophage function |
| 05/22/2008 | US20080119412 Polypeptides for Modulating Binding of Trp Channel Proteins and Trp- Associated Proteins |
| 05/22/2008 | US20080119411 use of salmon calcitonin in combination with PTH for the oral administration of PTH for the treatment of osteoporosis without the potentially toxic hypercalcemic side effects |
| 05/22/2008 | US20080118570 Polymer coated drug-ion exchange resins and methods |
| 05/22/2008 | US20080118566 Micronizing mometasone furoate and lactose particles, wherein at least one has a convertible amorphous content, homogenizing, agglomerating, converting the amorphous to crystalline |
| 05/22/2008 | US20080118565 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
| 05/22/2008 | US20080118562 Encapsulated by a biocompatible polymer shell; decreased toxicity of anticarcinogenic agents; side effect reduction |
| 05/22/2008 | US20080118560 Spray congealed 5-amido-7-benzyl(oxy or amino)imidazo[1,2-a]pyridines, at least one each of hydrophilic and hydrophobic matrix formers; antisecretory agents with improved water solubility, bioavailability and pharmacokinetics |
| 05/22/2008 | US20080118552 Finely Divided Composition Containing Poorly Water Soluble Substance |
| 05/22/2008 | US20080118546 Bioabsorbable polymeric composition for a medical device |
| 05/22/2008 | US20080118543 An interpenetrating polymer network of a poly(C1-C4 alkyl (meth)acrylate) bulk polymer and a polyoxyalkylene glycol homopolymer or copolymer additive; controlled release coatings |
| 05/22/2008 | US20080118542 Growth Factor Composition |
| 05/22/2008 | US20080118481 Mononuclear phagocytes in therapeutic drug delivery |
| 05/22/2008 | US20080116608 Molded waveguides |
| 05/22/2008 | US20080115782 Pressurised metered dose inhalers (mdi) |
| 05/22/2008 | CA2705785A1 Use of lipid conjugates in the treatment of diseases or disorders of the eye |
| 05/22/2008 | CA2693918A1 Matrix-embedded compositions having organic acids and fatty acids |
| 05/22/2008 | CA2678225A1 Transnasal anticonvulsive pharmaceutical composition |
| 05/22/2008 | CA2669539A1 Topical compositions comprising polyhydroxy acids and/or lactones for improved cutaneous effects of oxidative therapeutic drugs |
| 05/22/2008 | CA2669489A1 Liquid pharmaceutical compositions comprising a bisphosphonate compound |
| 05/22/2008 | CA2669488A1 Pharmaceutical compositions comprising a bisphosphonate compound |
| 05/22/2008 | CA2669485A1 Papaya mosaic virus-based vaccines for influenza |
| 05/22/2008 | CA2668503A1 Cancerous disease modifying antibodies 180706-01 |
| 05/22/2008 | CA2668496A1 Cancerous disease modifying antibodies |
| 05/22/2008 | CA2668484A1 Cancerous disease modifying antibodies 180706-02 |
| 05/22/2008 | CA2666182A1 Peg modified exendin or exendin analog and compositions and use thereof |
| 05/22/2008 | CA2664879A1 Biodegradable ocular implants and methods for treating ocular conditions |
| 05/22/2008 | CA2663854A1 Methods and compositions for gene therapy |
| 05/21/2008 | EP1923074A1 Orally disintegratable tablet |
| 05/21/2008 | EP1923051A1 Microparticle of hardly-soluble substance having enteric base material adsorbed on the surface of the substance |
| 05/21/2008 | EP1923049A1 Pharmaceutical compositions comprising a bisphosphonate compound |
| 05/21/2008 | EP1922350A2 Methods for preparing polymeric reagents and compositions of polymeric reagents |
| 05/21/2008 | EP1922330A1 Pseudomonas exotoxin a cd4+ t-cell epitopes |
| 05/21/2008 | EP1922328A1 Peptides targeted to protein kinase c isoforms and uses thereof |
| 05/21/2008 | EP1922090A2 Sanitary napkins with hydrophobic lotions |
| 05/21/2008 | EP1922087A2 Method for the preparation of polymeric conjugates of doxorubicin with ph-controlled release of the drug |
| 05/21/2008 | EP1922086A1 Targeted protein kinase c inhibitors and uses thereof |
| 05/21/2008 | EP1922076A2 Use of lipid conjugates in cystic fibrosis and applications thereof |
| 05/21/2008 | EP1922019A2 Tri-block copolymers for nanosphere-based drug delivery |
| 05/21/2008 | EP1730199A4 Native plant cell wall compositions and methods of use |
| 05/21/2008 | EP1670487A4 Therapeutic formulations |
| 05/21/2008 | EP1482981B1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 05/21/2008 | EP1360202B1 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
| 05/21/2008 | EP1326838B1 Novel crystalline forms of a factor xa inhibitor |
| 05/21/2008 | EP1313453B1 Particulate vectors for improving oral absorption of active principles |
| 05/21/2008 | EP1287130B1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/21/2008 | EP1284740B1 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with monosaccharide-based compounds |
| 05/21/2008 | EP1249239B1 Antipruritic agents for external use |
| 05/21/2008 | DE20221841U1 Transdermal-Pflaster zum Verabreichen von Fentanyl Transdermal patch for administering fentanyl |
| 05/21/2008 | CN101184850A Branched starch, process for production thereof, and use thereof |
| 05/21/2008 | CN101184511A Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen |
| 05/21/2008 | CN101184510A Methods of treating various conditions by administration of sustained release l-arginine |
| 05/21/2008 | CN101184499A Intranasal administration of active agents to the central nervous system |
| 05/21/2008 | CN101184497A Method of improving immune function in mammals using lactobacillus strains with certain lipids |
| 05/21/2008 | CN101184494A Method for preparing and separating phospholipids |
| 05/21/2008 | CN101184489A Pharmaceutical composition |
| 05/21/2008 | CN101184479A Skin patch |
| 05/21/2008 | CN101184475A Transdermal absorption accelerator |
| 05/21/2008 | CN101184473A Composition for use in the solubilisation of hydrophobic active agents |
| 05/21/2008 | CN101182379A Highly inhibited starch fillers for films and capsules |
| 05/21/2008 | CN101182348A Preparation method of frozen sericin gel |
| 05/21/2008 | CN101182331A Adefovir dipivoxil ester colalin derivatives as well as preparation method and uses thereof |
| 05/21/2008 | CN101182309A Targeted leading compounds having latent anticancer actives |
| 05/21/2008 | CN101181640A Hydrophilicity high elasticity gel rubber stroma of treating medical ointment and preparation method thereof |